Home > Insider Trading > Filing (0001562180-21-007528)

Filing Details

Accession Number:: 0001562180-21-007528
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-07 16:13:39
Reporting Period:: 2021-12-02

Accepted Time:: 2021-12-07 16:13:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636422	Health Catalyst Inc.	HCAT	Services-Computer Programming, Data Processing, Etc. (7370)	453337483

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780978	Paul Horstmeier	C/O Health Catalyst, Inc. 10897 South River Front Parkway, #300 South Jordan UT 84095	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-12-02	9,261	$41.95	99,180	No	4	F	Direct
Common Stock	Disposition	2021-12-06	600	$37.97	98,580	No	4	S	Direct
Common Stock	Disposition	2021-12-06	2,674	$38.76	95,906	No	4	S	Direct
Common Stock	Disposition	2021-12-06	2,789	$39.89	93,117	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.
The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1.
Represents the weighted average sale price of the shares sold ranging from $37.47 to $38.43 per share, inclusive.
Represents the weighted average sale price of the shares sold ranging from $38.47 to $39.24 per share, inclusive.
Represents the weighted average sale price of the shares sold ranging from $39.66 to $40.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) through (6).